Research programme: PPAR alpha agonists - Chipscreen BiosciencesAlternative Names: CS 207; CS 307
Latest Information Update: 06 Apr 2010
At a glance
- Originator Chipscreen Biosciences
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cardiovascular disorders; Lipid metabolism disorders
Most Recent Events
- 06 Apr 2010 Discontinued for Lipid metabolism disorders in China (unspecified route)
- 06 Apr 2010 Discontinued for Cardiovascular disorders in China (unspecified route)
- 15 Aug 2007 Early research in Lipid metabolism disorders in China (unspecified route)